The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The potential in artificial intelligence-driven radiomic signature to predict survival in patients with metastatic colorectal cancer treated with cetuximab-based therapy.
 
Laurent Dercle
No Relationships to Disclose
 
Lin Lu
No Relationships to Disclose
 
Lawrence Howard Schwartz
Consulting or Advisory Role - Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche
Research Funding - Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Millenium Pharamceuticals (Inst); Millenium Pharamceuticals (Inst); Millenium Pharamceuticals (Inst); Millenium Pharamceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems
 
Min Qian
No Relationships to Disclose
 
Sabine Tejpar
Honoraria - Merck Serono; Merck Serono; Merck Serono; Merck Serono; Regeneron; Regeneron; Regeneron; Regeneron
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Regeneron; Regeneron; Regeneron; Regeneron; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi
 
Peter Eggleton
Employment - Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Merck; Merck; Merck; Merck
 
Binsheng Zhao
Patents, Royalties, Other Intellectual Property - Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems
 
Hubert Piessevaux
Honoraria - Menarini; Menarini; Menarini; Menarini